Skip to main content
Visit Temple.edu
Toggle Utility Menu
Visit
Apply
Alumni
TUportal
Search Site
Search
Temple Now
Navigation
- Go To -
News by topic
- Arts & Culture
- Athletics
- Campus News
- Community Engagement
- Global Temple
- Research
- Staff & Faculty
- Student Success
- Sustainability
- Faculty Experts
- Public Safety
- Return to Campus
- Nutshell
- Visualize Temple
Announcements
Newsletters
- Temple Now subscription
Publications
Temple in the news
Social Media
Special Series
Temple Magazine
About
Accolades
News by topic
Announcements
Newsletters
About
Arts & Culture
Bad Bunny is headlining the 2026 Super Bowl halftime show. Here’s why it matters.
Athletics
A new era for the Cherry Crusade, Temple’s official student section of devoted Owls’ fans
Campus News
Temple hosts budget model workshops
Community Engagement
Police officer helps inspire a jump in Carver High School enrollment at Temple
Faculty Experts
During America’s 250th, Philadelphia will take center stage
Global Temple
Temple students learn about sustainability in Costa Rica study abroad program
Nutshell
Temple students’ guide to Election Day 2025
Public Safety
Black Pre-law Association Brings Halloween Cheer to North Philadelphia
Research
Temple research brings new voice to people with communication limitations
Return to Campus
A recap of Temple move-in and Weeks of Welcome 2024
Staff & Faculty
Temple Law’s Rachel López is reimagining the legal system
Student Success
Load up on these interesting courses next semester
Sustainability
Tyler glass program receives a grant to install carbon-friendly electric furnace
Visualize Temple
Charles Library shapes the future at Temple and beyond
View Archives
Home
/
Gerard Criner. Temple Lung Center
Gerard Criner. Temple Lung Center
Temple treats first patient in the U.S. in a new clinical trial for treatment of COVID-19
Type:
News Story
Temple’s Gerard Criner is the principal investigator at Temple University Hospital for a new clinical trial evaluating a potential treatment for COVID-19 patients.
April 28, 2020
